A股收評：三大指數震盪收跌，創新藥集體活躍，大金融回調
7月16日，滬指收跌0.03%報3503點，深證成指收跌0.22%，創業板指收跌0.22%。
全天成交1.46萬億元，較前一交易日縮量1733億元，全市場近3300股上漲。
盤面上，創新藥板塊走強，機器人執行器板塊活躍，肝素、肝炎概念走高，減肥藥、盲盒經濟、教育及汽車零部件等板塊漲幅居前。
另外，鋼鐵板塊普跌，PCB板塊走低，有機硅板塊調整，能源金屬、稀土永磁及保險等板塊跌幅居前。
具體來看：
創新藥集體活躍，哈三聯、潤都股份、奧賽康、萬邦德、麗珠集團、千紅製藥等多股漲停。近期，經國務院同意，國家醫保局聯合國家衛生健康委出臺《支持創新藥高質量發展的若幹措施》，提出5方面16條措施，主要包括：（1）加大創新藥研發支持力度；（2）支持創新藥進入基本醫保藥品目錄和商業健康保險創新藥品目錄；（3）支持創新藥臨牀應用；（4）提高創新藥多元支付能力；（5）強化保障措施。
英偉達概念延續漲勢，中電港2連板，鴻博股份漲停，寒武紀漲近5%。消息面上，今日英偉達黃仁勳出席第三屆鏈博會並在開幕式上致辭。他表示，世界上50%的人工智能研究人員都在中國，中國AI產業充滿活力，中國AI模型也是“世界級”的。AI的下一波浪潮將是機器人系統。此前，他宣佈H20將恢復在華銷售。
機器人概念股走強，上維新材、電光科技、福達股份、浙江榮泰、豪能股份等多股漲停。消息面上，在國務院新聞辦公室舉辦的“新徵程上的奮鬥者”中外記者見面會上，杭州宇樹科技股份有限公司創始人兼首席執行官王興興表示，今年宇樹科技機器人的出貨量相對於去年有明顯的增長。
教育股上漲，豆神教育漲超4%，中國高科、學大教育漲超3%，科德教育漲超2%。
汽車零部件概念股上揚，長源東谷、動力新科、嶸泰股份、福達股份、浙江榮泰等多股漲停。
遊戲股走低，冰川網絡、ST華通跌超5%，巨人網絡、星輝娛樂跌超2%。
大金融走低，銀行、保險、證券股下跌，廈門銀行、齊魯銀行、新華保險跌超2%。貴陽銀行、中國人保、廣發證券等紛紛跟跌。
個股方面，A股年內最大IPO企業華電新能今日正式上市。
N華新(600930.SH)今日高開高走，兩度觸發臨停，盤中一度大漲219.81%至10.17元，市值達4166億元。截至收盤，漲125.79%報7.18元，總市值2941.57億元。
展望後市，中信建投證券認爲，“上臺階”行情有望延續。流動性充裕疊加市場情緒升溫，推動A股“上臺階”。外部環境也較爲有利，積極情緒或蔓延至A股。
接下來，繼續維持戰略樂觀判斷，目前海內外宏觀環境、市場風險偏好和新賽道結構性景氣均出現積極信號，預計市場有望進一步“上臺階”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
